Internal Medicine Journal · 2007 · 73 citations · 17 references
MedicineEndocrinologyGeriatric MedicineAgingHuman NutritionNutrition In Older AdultsThyroid DisordersThyroid EndocrinologyOlder Adult PopulationOutcome MeasuresSerum Thyroid-stimulating Hormone MeasurementSubclinical HypothyroidismThyroid Function EvaluationThyroid Function TestingThyroid Function TestsThyroid-stimulating Hormone Testing
AIM: To determine the prevalence of thyroid disease in an older Australian population in a population-based cross-sectional study. BACKGROUND: Community-living subjects, aged 49 years or older, in two Blue Mountains postcodes were invited to participate in an eye, nutrition and health study between 1997 and 2000. METHODS: Three thousand five hundred and nine of the 4489 identified persons participated. Fifty-seven per cent of 3504 who completed questionnaires were women; their mean age was 66.8 years. Thyroid-stimulating hormone (TSH) was measured in 2665 subjects (76% of those completing the questionnaire). The main outcome measures were serum TSH and free thyroxine levels, serum lipids, urate and sugar levels and questionnaire responses. RESULTS: The prevalence of recognized thyroid disease (either self-reported history of thyroid disease or current thyroxine treatment) was 10% (95% confidence interval (CI) 8.9-11.1%). An additional 3.6% (95%CI 2.9-4.3%) of participants had unrecognized thyroid disease (abnormal TSH). The TSH was abnormal in 7.1% (95%CI 5.8-8.4%) of women and 3.7% (95%CI 2.6-4.8%) of men. Sixty-five per cent of those with an abnormal TSH did not report a history of thyroid disease, whereas 25% of those taking thyroxine replacement therapy had an abnormal TSH level. The prevalence of hypothyroidism increased with increasing age in women. The mean fasting cholesterol was 0.36 mmol/L (95%CI 0.15-0.57) higher in hypothyroid subjects than in euthyroid subjects. CONCLUSION: Thyroid disease in older Australian women is relatively common and may be undiagnosed. Ongoing monitoring of patients on thyroxine replacement therapy is important, given that 25% of treated patients had an abnormal TSH.
17
Joseph G. Hollowell, N Staehling, W. Dana Flanders et al. · The Journal of Clinical Endocrinology & Metabolism · 2002 · 3.9K citations
The Colorado Thyroid Disease Prevalence Study
Gay J. Canaris, Neil Manowitz, Gilbert H. Mayor et al. · Archives of Internal Medicine · 2000 · 2.8K citations
THE SPECTRUM OF THYROID DISEASE IN A COMMUNITY: THE WHICKHAM SURVEY
W. M. G. Tunbridge, D C Evered, R. Hall et al. · Clinical Endocrinology · 1977 · 2.7K citations
Visual Acuity and the Causes of Visual Loss in Australia
Karin Attebo, Paul Mitchell, Wayne Smith · Ophthalmology · 1996 · 806 citations
Medicine, Ophthalmology, Optometry +14
Jostein Holmen, Kristian Midthjell, Kristin Hunstad et al. · European Journal of Endocrinology · 2000 · 468 citations · Full text